• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page








Ammon is in bankruptcy, no one wants to be hit with the truth so it seems. There were claims that said it was done and everyone stated otherwise. They owe money everywhere, and don’t even have a parking lot anymore like they once did. Each floor has an hate for each other, they have no loyalty to each other, leave out the company they work for. Loyalty is questionable. The few lab staff who do the work are the people who do the most. Big accounts are lost, the measly ones left can’t sustain the debt left. Every lab is in danger, but Ammon’s danger zone is a big downward spiral. It’s a miracle if checks are received on time.

If it’s high school drama, let it simmer, there’s no need to refute and prove “superiority”.
 




So spot on ! The people cut are sooo bitter they were not chosen !

It’s literally because at some point you said no to something - I mean MA - we all knew - you even knew ! You said no to a simple task - you felt it was beneath you. Ammon was going under - asking its surviving employees to take on many hats ! You literally said no !

The surviving employees all took on whatever it took - cleaning bathrooms, stocking toilet paper, etc.

So are they losers ? Maybe ? But they still have jobs !
 




Is everyone in 2023 just a complete fool ? When a company files for chapter 11 - that means a reorganization and fully functioning company post ! Very rare and hard to achieve. But It means all that past due debt is negotiated - any vendor ever has the opportunity and responsibility to file a “claim”. It goes thru court and gets denied or pro rated ! Check the records fools !
 




Kudos to the people who do the lab work. They could just stop one day and that would be the end of it all. The labs around are all under pressure and will fall to the two major labs left now. Bankruptcy and selling is the option many have taken until the train ride ends. Ammon isn’t an exception. Bank your time and effort into places like LabCorp or LabQuest. Check the records for those labs, and compare it to the rest inclusive of Ammon. It is what it is.
 




Kudos to the people who do the lab work. They could just stop one day and that would be the end of it all. The labs around are all under pressure and will fall to the two major labs left now. Bankruptcy and selling is the option many have taken until the train ride ends. Ammon isn’t an exception. Bank your time and effort into places like LabCorp or LabQuest. Check the records for those labs, and compare it to the rest inclusive of Ammon. It is what it is.


Without working specimen processors there’s no way of income. That’s the premise of lab work getting done.
 




Aw you hurt bruh

Feeling hurt stems from the absence of recognition for those who give their utmost effort, aka the laboratory processing agents, minus the small minority that don’t add. The laboratory processing agents are the most valuable resources. If anyone from their team is absent or unwell, it poses significant challenges. When a specimen can't be analyzed, it results in a financial setback. Laboratories work that way. They rightfully deserve acknowledgment since they are the key players involved; without them, success would be jeopardized and money would if any wouldn’t materialize. Regrettably, they receive minimal recognition, it's uncertain if that will ever change. This situation appears unsustainable and is leading to a future of burden and overall dismay.
 




Feeling hurt stems from the absence of recognition for those who give their utmost effort, aka the laboratory processing agents, minus the small minority that don’t add. The laboratory processing agents are the most valuable resources. If anyone from their team is absent or unwell, it poses significant challenges. When a specimen can't be analyzed, it results in a financial setback. Laboratories work that way. They rightfully deserve acknowledgment since they are the key players involved; without them, success would be jeopardized and money would if any wouldn’t materialize. Regrettably, they receive minimal recognition, it's uncertain if that will ever change. This situation appears unsustainable and is leading to a future of burden and overall dismay.

The above verifies everything concisely. Every toxicology business owner knows the outcomes. Ammon and all the other popular labs besides LC/LQ are failing. Lab processors are the front line workers that are working tirelessly. All is in jeopardy.
 




Is everyone in 2023 just a complete fool ? When a company files for chapter 11 - that means a reorganization and fully functioning company post ! Very rare and hard to achieve. But It means all that past due debt is negotiated - any vendor ever has the opportunity and responsibility to file a “claim”. It goes thru court and gets denied or pro rated ! Check the records fools !

The issue with Ammon is not the Chapter 11 Filing. The debt was renegotiated with their creditors. The problem for Ammon is the HRSA claim against them. That is not a normal creditor and will still be owed once the leave Chapter 11. Ammon is trying to get that dismissed before they come out. That is a tough fight. Once a government agency files a claim the courts do not discharge it, they allow it to move forward once out of Chapter 11. Ammon has a real issue here.
 




So they processed fraudulent claims to HRSA? Makes sense, all those women in billing did prior to Innovative taking over was order Chinese food & gossip. Doubt they saw anything with the 20lbs of lashes they had on. The VP of billing (LM), supervisor (TB) & team lead (IG) were all a disaster. SD didn't help their situation.
 




The issue with Ammon is not the Chapter 11 Filing. The debt was renegotiated with their creditors. The problem for Ammon is the HRSA claim against them. That is not a normal creditor and will still be owed once the leave Chapter 11. Ammon is trying to get that dismissed before they come out. That is a tough fight. Once a government agency files a claim the courts do not discharge it, they allow it to move forward once out of Chapter 11. Ammon has a real issue here.

Through this civil discourse, the primary focal point here is the main argument being underscored fully. Critiques were made, but this outlines the whispers in the toxicology industry. While numerous factors contribute to a bankruptcy scenario, the HRSA claim, as noted, stands out as a critical obstacle. It's not unreasonable or ‘foolish’ to acknowledge the large discrepancies of bankruptcy, but also failing to address the hidden intricacies around of the HRSA claim might be seen as what’s deemed to be unwise. This adds a bruising layer of complexity to the circumstances, thus making Ammon's already arduous voyage is more complicated than optimistic.
 




Through this civil discourse, the primary focal point here is the main argument being underscored fully. Critiques were made, but this outlines the whispers in the toxicology industry. While numerous factors contribute to a bankruptcy scenario, the HRSA claim, as noted, stands out as a critical obstacle. It's not unreasonable or ‘foolish’ to acknowledge the large discrepancies of bankruptcy, but also failing to address the hidden intricacies around of the HRSA claim might be seen as what’s deemed to be unwise. This adds a bruising layer of complexity to the circumstances, thus making Ammon's already arduous voyage is more complicated than optimistic.

"Four score and seven years ago our fathers brought forth, upon this continent, a new nation, conceived....."

What the hell are you bloviating about? You make no sense while trying to sound smart. Thanks for your response Hemingway!
 












The issue with Ammon is not the Chapter 11 Filing. The debt was renegotiated with their creditors. The problem for Ammon is the HRSA claim against them. That is not a normal creditor and will still be owed once the leave Chapter 11. Ammon is trying to get that dismissed before they come out. That is a tough fight. Once a government agency files a claim the courts do not discharge it, they allow it to move forward once out of Chapter 11. Ammon has a real issue here.

It’s just a series of unfortunate events, for toxicology laboratories like Ammon. Better than ever turned into the opposite for now. This seems like more than an expensive pursuit, but time consuming one.
 








"Four score and seven years ago our fathers brought forth, upon this continent, a new nation, conceived....."

What the hell are you bloviating about? You make no sense while trying to sound smart. Thanks for your response Hemingway!


As a light hearted joke/comic relief in a tense discussion , bloviating gives some of that founding father attribute.

All jokes aside though, everyone agrees that better in this industry is an understatement at most.